Artificial Intelligence in Precision Oncology—Opportunities and Challenges

The 2025 ESMO Congress covered a wide range of translational and clinical topics, with the growing importance of artificial intelligence (AI) in diagnosis, prognosis, and treatment decisions standing out in particular. In his presentation titled “AI in Precision Oncology of Liver Cancer,” Prof. Julien Calderaro (Henri Mondor University Hospital, Créteil) presented the latest findings on the use of AI-based methods in precision oncology for liver cancer and highlighted diagnostic, prognostic, and treatment-related aspects.